Valuation: Celltrion, Inc.

Market Cap 41,71200Cr 3.1TCr 2.75TCr 2.57TCr 2.34TCr 4.42TCr 2,97700Cr 4.46TCr 31TCr 12TCr 1,52200Cr 12TCr 11TCr 4,88500Cr P/E 2026 *
27.6x
P/E 2027 * 23.7x
Enterprise Value 4.39TCr 3.26Cr 2.9Cr 2.7Cr 2.46Cr 4.65Cr 313.43Cr 4.69Cr 33Cr 13Cr 160.23Cr 12Cr 12Cr 514.24Cr EV / Sales 2026 *
7.93x
EV / Sales 2027 * 6.78x
Free-Float
60.59%
Yield 2026 *
0.41%
Yield 2027 * 0.43%
1 day-0.54%
1 week+2.93%
Current month+2.76%
1 month-2.41%
3 months-0.54%
6 months-1.83%
Current year+5.93%
1 week 1,75,500
Extreme 175500
1,84,200
1 month 1,74,600
Extreme 174600
1,90,000
Current year 1,58,500
Extreme 158500
2,39,047.62
1 year 1,58,500
Extreme 158500
2,39,047.62
3 years 1,14,250.83
Extreme 114250.828535
2,39,047.62
5 years 1,14,250.83
Extreme 114250.828535
2,39,047.62
10 years 64,487.59
Extreme 64487.593381
3,25,235.48
Manager TitleAgeSince
Chief Executive Officer 65 20/03/2015
Chief Executive Officer 42 26/03/2021
President 51 13/02/2026
Director TitleAgeSince
Chairman 69 -
Director/Board Member 61 01/04/2005
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
16/01/26 Sell 500 0.0002%
16/01/26 Sell 1,000 0.0004%
16/01/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%+2.93% - - 3.1TCr
Average -0.54%
Weighted average by Cap. -0.54%

Financials

2026 *2027 *
Net sales 5,53500Cr 410.98Cr 365.16Cr 340.82Cr 310.64Cr 585.87Cr 40TCr 591.32Cr 4.12TCr 1.6TCr 20TCr 1.54TCr 1.51TCr 65TCr 6,35000Cr 471.48Cr 418.91Cr 390.98Cr 356.37Cr 672.11Cr 45TCr 678.37Cr 4.73TCr 1.83TCr 23TCr 1.77TCr 1.73TCr 74TCr
Net income 1,53800Cr 114.17Cr 101.44Cr 95Cr 86Cr 162.75Cr 11TCr 164.27Cr 1.15TCr 443.98Cr 5.61TCr 428.65Cr 419.34Cr 18TCr 1,78000Cr 132.16Cr 117.42Cr 109.59Cr 100Cr 188.39Cr 13TCr 190.15Cr 1.33TCr 513.93Cr 6.49TCr 496.18Cr 485.41Cr 21TCr
Net Debt 2,19800Cr 163.18Cr 144.98Cr 135.32Cr 123.34Cr 232.61Cr 16TCr 234.78Cr 1.64TCr 634.56Cr 8.02TCr 612.65Cr 599.35Cr 26TCr 1,31800Cr 98Cr 87Cr 81Cr 74Cr 139.51Cr 9.41TCr 140.81Cr 982.16Cr 380.59Cr 4.81TCr 367.44Cr 359.47Cr 15TCr
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
02/26/02 ₩1,82,600.00 -0.54% 3,19,980
01/26/01 ₩1,83,600.00 +3.32% 4,22,088
30/26/30 ₩1,77,700.00 -0.67% 3,52,051
29/26/29 ₩1,78,900.00 +0.34% 2,98,374
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
1,82,600.00KRW
Average target price
2,67,741.48KRW
Spread / Average Target
+46.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock